REMIFENTANIL HYDROCHLORIDE is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Navinta Llc. The primary component is Remifentanil Hydrochloride.
| Product ID | 68475-505_c6bfa062-45c2-460c-a923-b551732fa4af |
| NDC | 68475-505 |
| Product Type | Human Prescription Drug |
| Proprietary Name | REMIFENTANIL HYDROCHLORIDE |
| Generic Name | Remifentanil Hydrochloride |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-01-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210594 |
| Labeler Name | Navinta LLC |
| Substance Name | REMIFENTANIL HYDROCHLORIDE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2021-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9391 | REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE |
| 0143-9392 | REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE |
| 0143-9393 | REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE |
| 63323-723 | Remifentanil Hydrochloride | Remifentanil Hydrochloride |
| 63323-724 | Remifentanil Hydrochloride | Remifentanil Hydrochloride |
| 63323-725 | Remifentanil Hydrochloride | Remifentanil Hydrochloride |
| 68475-505 | REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE |
| 68475-506 | REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE |
| 68475-507 | REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE |
| 67457-198 | Ultiva | Remifentanil Hydrochloride |
| 67457-912 | Ultiva | Remifentanil Hydrochloride |
| 67457-913 | Ultiva | Remifentanil Hydrochloride |
| 67457-914 | Ultiva | Remifentanil Hydrochloride |